ICU Medical is a medical - instruments & supplies company in the healthcare sector trading on NASDAQ, led by CEO Vivek Jain, with a market cap of $3.1B.
Upcoming earnings announcement for ICU Medical
Past 12 earnings reports for ICU Medical
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 19, 2026 | Q4 2025 | $1.91Est: $1.54 | +24.0% | $540.7MEst: $536.3M | +0.8% | |
| Nov 6, 2025 | Q3 2025 | $2.03Est: $1.31 | +55.0% | $537.0MEst: $512.7M | +4.7% | |
| Aug 7, 2025 | Q2 2025 | $2.10Est: $1.36 | +54.4% | $548.9MEst: $540.5M | +1.6% | |
| May 8, 2025 | Q1 2025 | $1.72Est: $1.28 | +34.4% | $604.7MEst: $574.2M | +5.3% | |
| Feb 27, 2025 | Q4 2024 | $2.11Est: $1.48 | +42.6% | $629.8MEst: $599.1M | +5.1% | |
| Nov 12, 2024 | Q3 2024 | $1.59Est: $1.25 | +27.2% | $589.1MEst: $574.7M | +2.5% | |
| Aug 7, 2024 | Q2 2024 | $1.56Est: $1.00 | +56.0% | $596.5MEst: $553.7M | +7.7% | |
| May 7, 2024 | Q1 2024 | $0.96Est: $0.82 | +17.1% | $566.7MEst: $552.3M | +2.6% | |
| Feb 27, 2024 | Q4 2023 | $1.57Est: $1.19 | +31.9% | $587.9MEst: $563.0M | +4.4% | |
| Nov 6, 2023 | Q3 2023 | $1.57Est: $1.38 | +13.8% | $553.3MEst: $565.8M | -2.2% | — |
| Aug 7, 2023 | Q2 2023 | $1.88Est: $1.55 | +21.3% | $549.3MEst: $562.9M | -2.4% | |
| May 8, 2023 | Q1 2023 | $1.74Est: $1.43 | +21.7% | $568.6MEst: $565.3M | +0.6% | — |
We use cookies for analytics. See our Privacy and Cookie Policy.